These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 16938288)

  • 41. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
    Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
    J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
    Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
    Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
    Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
    Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
    Washida K; Ihara M; Nishio K; Fujita Y; Maki T; Yamada M; Takahashi J; Wu X; Kihara T; Ito H; Tomimoto H; Takahashi R
    Stroke; 2010 Aug; 41(8):1798-806. PubMed ID: 20595663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
    Kurihara T; Ozawa Y; Shinoda K; Nagai N; Inoue M; Oike Y; Tsubota K; Ishida S; Okano H
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5545-52. PubMed ID: 17122147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
    Yao Y; Zou R; Liu X; Jiang J; Huang Q; He Y; Li M; Wang S; Zhou J; Ma D; Xu G
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):543-8. PubMed ID: 18846335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells.
    Kociecka B; Surazynski A; Miltyk W; Palka J
    Eur J Pharmacol; 2010 Feb; 628(1-3):51-6. PubMed ID: 19945454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.
    Mizuno CS; Chittiboyina AG; Shah FH; Patny A; Kurtz TW; Pershadsingh HA; Speth RC; Karamyan VT; Carvalho PB; Avery MA
    J Med Chem; 2010 Feb; 53(3):1076-85. PubMed ID: 20073471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression.
    Zhong JC; Ye JY; Jin HY; Yu X; Yu HM; Zhu DL; Gao PJ; Huang DY; Shuster M; Loibner H; Guo JM; Yu XY; Xiao BX; Gong ZH; Penninger JM; Oudit GY
    Regul Pept; 2011 Jan; 166(1-3):90-7. PubMed ID: 20854846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism.
    Saravanan PB; Shanmuganathan MV; Ramanathan M
    Life Sci; 2015 Jun; 130():88-96. PubMed ID: 25816983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
    Shiota A; Shimabukuro M; Fukuda D; Soeki T; Sato H; Uematsu E; Hirata Y; Kurobe H; Maeda N; Sakaue H; Masuzaki H; Shimomura I; Sata M
    Cardiovasc Diabetol; 2012 Nov; 11():139. PubMed ID: 23137106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
    Min Q; Bai YT; Jia G; Wu J; Xiang JZ
    Exp Mol Pathol; 2010 Feb; 88(1):133-7. PubMed ID: 19796634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage.
    Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ
    Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
    Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
    Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.
    Huang Y; Di Lorenzo A; Jiang W; Cantalupo A; Sessa WC; Giordano FJ
    Hypertension; 2013 Sep; 62(3):634-40. PubMed ID: 23918749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.